HALOPERIDOL
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
82619-109 -
Package NDC
82619-109-01 -
Package NDC
82619-109-02 -
Package NDC
82619-109-03 -
Application number
ANDA218162 -
SPL ID
46d58435-0437-e206-e063-6294a90ae755 -
SPL set ID
9763c044-7430-48f7-bf3e-da1c7c683955 -
UNII
J6292F8L3D -
RxCUI
197754 -
RxCUI
310670 -
RxCUI
310671 -
RxCUI
310672 -
RxCUI
314034 -
RxCUI
314035
What the source publishes
- Labeler
- Creekwood Pharmaceuticals LLC
- Active ingredients
- haloperidol
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "HALOPERIDOL",
"splId": "46d58435-0437-e206-e063-6294a90ae755",
"labels": [
{
"setId": "9763c044-7430-48f7-bf3e-da1c7c683955",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9763c044-7430-48f7-bf3e-da1c7c683955",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9763c044-7430-48f7-bf3e-da1c7c683955"
}
],
"routes": [
"ORAL"
],
"labeler": "Creekwood Pharmaceuticals LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE (82619-109-01)",
"package_ndc": "82619-109-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20260105"
},
{
"sample": false,
"description": "100 TABLET in 1 BOTTLE (82619-109-02)",
"package_ndc": "82619-109-02",
"identifierStatus": "well-formed",
"marketing_start_date": "20260105"
},
{
"sample": false,
"description": "1000 TABLET in 1 BOTTLE (82619-109-03)",
"package_ndc": "82619-109-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20260105"
}
],
"productId": "82619-109_46d58435-0437-e206-e063-6294a90ae755",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "82619-109",
"deaSchedule": null,
"genericName": "haloperidol",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "HALOPERIDOL",
"strength": "10 mg/1"
}
],
"applicationNumber": "ANDA218162",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260105",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000180182"
],
"upc": [
"0382619105018",
"0382619105025",
"0382619108033",
"0382619109023",
"0382619109016",
"0382619109030",
"0382619110029",
"0382619106022",
"0382619107029",
"0382619106015",
"0382619107012",
"0382619108026"
],
"unii": [
"J6292F8L3D"
],
"rxcui": [
"197754",
"310670",
"310671",
"310672",
"314034",
"314035"
],
"spl_set_id": [
"9763c044-7430-48f7-bf3e-da1c7c683955"
],
"pharm_class_epc": [
"Typical Antipsychotic [EPC]"
],
"manufacturer_name": [
"Creekwood Pharmaceuticals LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:82619-109_46d58435-0437-e206-e063-6294a90ae755"